Literature DB >> 17569611

Role of "handle" region of prorenin prosegment in the non-proteolytic activation of prorenin by binding to membrane anchored (pro)renin receptor.

Nabi A H M Nurun1, Nasir M Uddin, Tsutomu Nakagawa, Hideyuki Iwata, Atsuhiro Ichihara, Tadashi Inagami, Fumiaki Suzuki.   

Abstract

A role of the "handle" region in the prorenin prosegment sequence was investigated to demonstrate the crucial non-proteolytic activation of prorenin by binding to the recombinant (pro)renin receptor on the COS-7 cell membrane. The plasmid DNA containing either rat or human (pro)renin receptor was transfected into the COS-7 cells. The highest amount of receptor was observed on the COS-7 cell membrane after 18 h transfection. Of the total rat and human prorenin, 90% and 50% were bound to each of the respective receptors, respectively. The Kd values were 0.89 and 1.8 nM, respectively. Rat prorenin was activated non-proteolytically by the receptor. The Km was determined 1.0 microM when sheep angiotensinogen was used as the substrate. Human prorenin was also activated by the receptor. The Km was 0.71 microM. Additionally, decapeptides (10P-19P) known as "decoy" peptide and pentapeptides (11P-15P) named "handle" region peptide, were observed to inhibit the binding of both prorenins to receptors, respectively. The Ki were similar around 7 nM for both the peptides. Other two region peptides in the prosegment did not interfere the binding. These results show that the "handle" region probably plays a crucial role in prorenin binding to the receptor and in its enzymic activity by non-proteolytic activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17569611     DOI: 10.2741/2429

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  13 in total

Review 1.  Prorenin/renin receptor, signals, and therapeutic efficacy of receptor blocker in end-organ damage.

Authors:  Tadashi Inagami; Atsuhiro Ichihara
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

Review 2.  Renin and prorenin receptor in hypertension: what's new?

Authors:  Genevieve Nguyen
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

3.  Aliskiren reduces the release of soluble (pro)renin receptor from human umbilical vein endothelial cells.

Authors:  Shinji Yamashita; Kazal Boron Biswas; A H M Nurun Nabi; Tsutomu Nakagawa; Fumiaki Suzuki; Akio Ebihara
Journal:  Biomed Rep       Date:  2018-07-05

4.  (Pro)renin receptor: a treatment target for diabetic retinopathy?

Authors:  Jennifer L Wilkinson-Berka; Duncan J Campbell
Journal:  Diabetes       Date:  2009-07       Impact factor: 9.461

Review 5.  PLZF and the (pro)renin receptor.

Authors:  Jan H Schefe; Thomas Unger; Heiko Funke-Kaiser
Journal:  J Mol Med (Berl)       Date:  2008-03-12       Impact factor: 4.599

Review 6.  The critical role of the central nervous system (pro)renin receptor in regulating systemic blood pressure.

Authors:  Quanbin Xu; Dane D Jensen; Hua Peng; Yumei Feng
Journal:  Pharmacol Ther       Date:  2016-04-23       Impact factor: 12.310

Review 7.  Renin receptor blockade: a better strategy for renal protection than renin-angiotensin system inhibition?

Authors:  Dominik N Müller; Friedrich C Luft
Journal:  Curr Hypertens Rep       Date:  2008-10       Impact factor: 5.369

Review 8.  A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link?

Authors:  Adolfo E Cuadra; Zhiying Shan; Colin Sumners; Mohan K Raizada
Journal:  Pharmacol Ther       Date:  2009-08-31       Impact factor: 12.310

Review 9.  The (pro)renin receptor in health and disease.

Authors:  Atsuhiro Ichihara; Midori Sasaki Yatabe
Journal:  Nat Rev Nephrol       Date:  2019-11       Impact factor: 28.314

10.  (Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation.

Authors:  Shingo Satofuka; Atsuhiro Ichihara; Norihiro Nagai; Kousuke Noda; Yoko Ozawa; Akiyoshi Fukamizu; Kazuo Tsubota; Hiroshi Itoh; Yuichi Oike; Susumu Ishida
Journal:  Diabetes       Date:  2009-04-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.